1-2b revenue with cogs at 5% leaving the rest as profit.
clearly once this hits the market the company will be earning appro 1B US per annum. Factor in a discount for time and 50% for success we are clearly still way undervalued. Wait until the US works this out!
Note, there will be more drugs and a platform to add to the value of the company. I dont think I have enough, again!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
-0.075(5.28%) |
Mkt cap ! $784.4M | |||
| Open | High | Low | Value | Volume |
| $1.42 | $1.42 | $1.34 | $767.6K | 565.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9300 | $1.33 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.35 | 94318 | 1 |
View Market Depth
| Last trade - 16.10pm 23/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |